These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


193 related items for PubMed ID: 32909076

  • 1. A phase 2a randomised, double-blind, placebo-controlled, parallel-group, add-on clinical trial of ebselen (SPI-1005) as a novel treatment for mania or hypomania.
    Sharpley AL, Williams C, Holder AA, Godlewska BR, Singh N, Shanyinde M, MacDonald O, Cowen PJ.
    Psychopharmacology (Berl); 2020 Dec; 237(12):3773-3782. PubMed ID: 32909076
    [Abstract] [Full Text] [Related]

  • 2. Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study. European Valproate Mania Study Group.
    Müller-Oerlinghausen B, Retzow A, Henn FA, Giedke H, Walden J.
    J Clin Psychopharmacol; 2000 Apr; 20(2):195-203. PubMed ID: 10770458
    [Abstract] [Full Text] [Related]

  • 3. Adjunctive topiramate therapy in patients receiving a mood stabilizer for bipolar I disorder: a randomized, placebo-controlled trial.
    Roy Chengappa KN, Schwarzman LK, Hulihan JF, Xiang J, Rosenthal NR, Clinical Affairs Product Support Study-168 Investigators.
    J Clin Psychiatry; 2006 Nov; 67(11):1698-706. PubMed ID: 17196048
    [Abstract] [Full Text] [Related]

  • 4. Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial.
    Sachs GS, Vanderburg DG, Karayal ON, Kolluri S, Bachinsky M, Cavus I.
    J Clin Psychiatry; 2012 Nov; 73(11):1412-9. PubMed ID: 23218157
    [Abstract] [Full Text] [Related]

  • 5. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
    Vieta E, Owen R, Baudelet C, McQuade RD, Sanchez R, Marcus RN.
    Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
    [Abstract] [Full Text] [Related]

  • 6. Valproate or olanzapine add-on to lithium: an 8-week, randomized, open-label study in Italian patients with a manic relapse.
    Maina G, Albert U, Salvi V, Mancini M, Bogetto F.
    J Affect Disord; 2007 Apr; 99(1-3):247-51. PubMed ID: 17056122
    [Abstract] [Full Text] [Related]

  • 7. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP, Tohen M, Degenhardt EK, Jamal HH, Liu LL, Ketter TA.
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.
    Tohen M, Chengappa KN, Suppes T, Zarate CA, Calabrese JR, Bowden CL, Sachs GS, Kupfer DJ, Baker RW, Risser RC, Keeter EL, Feldman PD, Tollefson GD, Breier A.
    Arch Gen Psychiatry; 2002 Jan; 59(1):62-9. PubMed ID: 11779284
    [Abstract] [Full Text] [Related]

  • 9. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.
    Encephale; 2004 Jan; 30(5):417-24. PubMed ID: 15627046
    [Abstract] [Full Text] [Related]

  • 10. Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group.
    Pande AC, Crockatt JG, Janney CA, Werth JL, Tsaroucha G.
    Bipolar Disord; 2000 Sep; 2(3 Pt 2):249-55. PubMed ID: 11249802
    [Abstract] [Full Text] [Related]

  • 11. Safety and efficacy of ebselen for the prevention of noise-induced hearing loss: a randomised, double-blind, placebo-controlled, phase 2 trial.
    Kil J, Lobarinas E, Spankovich C, Griffiths SK, Antonelli PJ, Lynch ED, Le Prell CG.
    Lancet; 2017 Sep 02; 390(10098):969-979. PubMed ID: 28716314
    [Abstract] [Full Text] [Related]

  • 12. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
    Juruena MF, Ottoni GL, Machado-Vieira R, Carneiro RM, Weingarthner N, Marquardt AR, Fleig SS, Broilo L, Busnello EA.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb 01; 33(1):94-9. PubMed ID: 19007842
    [Abstract] [Full Text] [Related]

  • 13. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
    McIntyre RS, Konarski JZ, Jones M, Paulsson B.
    J Affect Disord; 2007 Feb 01; 100 Suppl 1():S5-14. PubMed ID: 17391773
    [Abstract] [Full Text] [Related]

  • 14. A randomized, double-blind, placebo- and risperidone-controlled study on valnoctamide for acute mania.
    Weiser M, Levi L, Levine SZ, Bialer M, Shekh-Ahmad T, Matei V, Tiugan A, Cirjaliu D, Sava C, Sinita E, Zamora D, Davis JM.
    Bipolar Disord; 2017 Jun 01; 19(4):285-294. PubMed ID: 28605109
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.
    van der Loos ML, Mulder PG, Hartong EG, Blom MB, Vergouwen AC, de Keyzer HJ, Notten PJ, Luteijn ML, Timmermans MA, Vieta E, Nolen WA, LamLit Study Group.
    J Clin Psychiatry; 2009 Feb 01; 70(2):223-31. PubMed ID: 19200421
    [Abstract] [Full Text] [Related]

  • 16. A double-blind, placebo-controlled trial of adjunctive donepezil in treatment-resistant mania.
    Eden Evins A, Demopulos C, Nierenberg A, Culhane MA, Eisner L, Sachs G.
    Bipolar Disord; 2006 Feb 01; 8(1):75-80. PubMed ID: 16411983
    [Abstract] [Full Text] [Related]

  • 17. A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes.
    Weisler RH, Kalali AH, Ketter TA, SPD417 Study Group.
    J Clin Psychiatry; 2004 Apr 01; 65(4):478-84. PubMed ID: 15119909
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of melatonin as an adjunct in the treatment of acute mania: a double-blind and placebo-controlled trial.
    Moghaddam HS, Bahmani S, Bayanati S, Mahdavinasa M, Rezaei F, Akhondzadeh S.
    Int Clin Psychopharmacol; 2020 Mar 01; 35(2):81-88. PubMed ID: 31743233
    [Abstract] [Full Text] [Related]

  • 19. Oxcarbazepine for acute affective episodes in bipolar disorder.
    Vasudev A, Macritchie K, Vasudev K, Watson S, Geddes J, Young AH.
    Cochrane Database Syst Rev; 2011 Dec 07; (12):CD004857. PubMed ID: 22161387
    [Abstract] [Full Text] [Related]

  • 20. Aripiprazole alone or in combination for acute mania.
    Brown R, Taylor MJ, Geddes J.
    Cochrane Database Syst Rev; 2013 Dec 17; 2013(12):CD005000. PubMed ID: 24346956
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.